InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21
InspireMD Appoints Acclaimed Interventional Cardiologist Kenneth Rosenfield, MD as Chair of its Newly Formed Scientific Advisory BoardGlobeNewsWire • 04/29/21
InspireMD CEO Marvin Slosman Issues Letter to Fellow Stockholders Urging Support of the Company's Plans to List its Common Stock on Nasdaq at the Upcoming Special Meeting of StockholdersGlobeNewsWire • 03/22/21
InspireMD, Inc.'s (NSPR) CEO Marvin Slosman on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/09/21
InspireMD to Report Fourth Quarter and Year-End 2020 Financial Results on Tuesday, March 9, 2021 and Provide Corporate UpdateGlobeNewsWire • 03/02/21
InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United StatesGlobeNewsWire • 02/24/21
InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United StatesGlobeNewsWire • 02/09/21
InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment OptionGlobeNewsWire • 02/08/21
InspireMD Announces Pricing of Upsized $18 Million Underwritten Public OfferingGlobeNewsWire • 02/04/21
InspireMD Secures Partner for Intended Registration and Distribution of CGuard EPS in Mainland ChinaGlobeNewsWire • 02/03/21
InspireMD's CGuard™ Featured in Multiple Presentations, Including a Live Case Demonstration During the Leipzig Interventional Congress January 25-29, 2021GlobeNewsWire • 01/26/21
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
UPDATE - InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a)GlobeNewsWire • 11/03/20
InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a)GlobeNewsWire • 11/03/20
InspireMD to Report Third Quarter 2020 Financial Results on Monday, November 9, 2020 and Provide Corporate UpdateGlobeNewsWire • 11/02/20